Startups

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Summary

Seedtable Score
  • 12
Locations
Company Size
  • 11 to 50 employees
Last Stage Round

Total funding Amount

$160M

Fundraising History

Investors